SOA Wealth Advisors LLC. Has $1.07 Million Holdings in Zoetis Inc. (NYSE:ZTS)

SOA Wealth Advisors LLC. raised its position in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 647,600.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,477 shares of the company's stock after buying an additional 6,476 shares during the quarter. SOA Wealth Advisors LLC.'s holdings in Zoetis were worth $1,066,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of ZTS. Norges Bank purchased a new stake in Zoetis during the fourth quarter valued at about $824,321,000. Wellington Management Group LLP lifted its stake in Zoetis by 78.5% during the fourth quarter. Wellington Management Group LLP now owns 6,958,543 shares of the company's stock valued at $1,133,755,000 after buying an additional 3,059,255 shares in the last quarter. Sarasin & Partners LLP purchased a new stake in Zoetis during the first quarter valued at about $339,111,000. GAMMA Investing LLC lifted its stake in Zoetis by 14,731.3% during the first quarter. GAMMA Investing LLC now owns 1,759,285 shares of the company's stock valued at $289,666,000 after buying an additional 1,747,423 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in Zoetis during the fourth quarter valued at about $196,651,000. 92.80% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

ZTS has been the subject of a number of analyst reports. Barclays upped their price objective on shares of Zoetis from $242.00 to $244.00 and gave the company an "overweight" rating in a research note on Friday, February 14th. Stifel Nicolaus dropped their target price on Zoetis from $180.00 to $165.00 and set a "buy" rating on the stock in a report on Monday, April 14th. Wall Street Zen upgraded Zoetis from a "hold" rating to a "buy" rating in a report on Friday, March 7th. Piper Sandler upped their target price on Zoetis from $205.00 to $210.00 and gave the company an "overweight" rating in a report on Monday, May 12th. Finally, UBS Group dropped their target price on Zoetis from $189.00 to $170.00 and set a "neutral" rating on the stock in a report on Wednesday, May 7th. One equities research analyst has rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, Zoetis presently has a consensus rating of "Buy" and an average price target of $212.75.

Zoetis Stock Up 0.9%

Shares of NYSE ZTS traded up $1.54 during trading hours on Friday, hitting $170.15. The stock had a trading volume of 1,505,404 shares, compared to its average volume of 2,539,913. The company has a market capitalization of $75.75 billion, a P/E ratio of 31.11, a P/E/G ratio of 2.78 and a beta of 0.94. The firm's 50-day moving average price is $157.41 and its two-hundred day moving average price is $164.29. Zoetis Inc. has a 52 week low of $139.70 and a 52 week high of $200.33. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.08 and a current ratio of 1.75.

Zoetis (NYSE:ZTS - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The company reported $1.48 EPS for the quarter, beating the consensus estimate of $1.40 by $0.08. The business had revenue of $2.22 billion during the quarter, compared to analysts' expectations of $2.20 billion. Zoetis had a return on equity of 53.82% and a net margin of 26.86%. The firm's quarterly revenue was up 1.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.38 EPS. Analysts anticipate that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 3rd. Investors of record on Friday, July 18th will be paid a $0.50 dividend. The ex-dividend date is Friday, July 18th. This represents a $2.00 annualized dividend and a dividend yield of 1.18%. Zoetis's payout ratio is 35.91%.

Insider Activity at Zoetis

In other Zoetis news, EVP Roxanne Lagano sold 326 shares of the company's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $170.00, for a total transaction of $55,420.00. Following the completion of the sale, the executive vice president now owns 15,781 shares of the company's stock, valued at $2,682,770. This represents a 2.02% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Willie M. Reed sold 1,210 shares of the company's stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $166.14, for a total value of $201,029.40. Following the sale, the director now directly owns 11,245 shares of the company's stock, valued at $1,868,244.30. The trade was a 9.71% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 2,188 shares of company stock valued at $367,289. 0.18% of the stock is owned by corporate insiders.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.